期刊文献+

多发性骨髓瘤患者外周血Th17和Treg细胞比率的平衡关系研究 被引量:12

Imbalance of Thl7 and Treg cells in peripheral blood from multiple myeloma patients
原文传递
导出
摘要 目的探讨多发性骨髓瘤(MM)患者外周血中辅助性T细胞17(Thl7)和CD4+CD25+Foxp3+渊节性T细胞(Treg细胞)比率的平衡关系及其在MM发病机制中的作用。方法70例MM患者分为初发组30例,平台期组23例,复发/难治组17例,以20名健康体检者为正常对照组。流式细胞术检测MM患者和正常对照者外周血中T细胞亚群及Thl7和Treg细胞占CD4+T细胞的比率。结果初发组及复发,难治组患者外周I血Thl7细胞的比率分别为(1.62±0.65)%和(1.45±0.51)%,与正常对照组[(0.72±0,33)%]及平台期组[(0.74±0.29)%]比较,均明显增高(P值均〈0.05);Treg细胞比率分别为(0.55±0.23)%和(0.82±0.54)%,与正常对照组[(2.33±0.90)%]及平台期组[(1.69±0.70)%]比较,明显减低(P值均〈O.05),Thl7/Treg细胞比值明显增高(P值均〈0.05);平台期患者CD3+CD4+T细胞以及Thl7细胞比率与正常对照组比较差异无统计学意义(P〉0.05),Treg细胞比率明显低于正常对照组,Thl7/Treg细胞比值明冠高于正常对照组。结论MM患者外周【衄T细胞亚群紊乱以CD4+T细胞减少为主,MM患者体内存在Thl7细胞比率升高和Treg细胞比率降低所致的Thl7/Treg细胞比例失衡,随疾病稳定而趋于正常,该免疫失衡可能在MM的发生、发展中起重要作用。 Objective To investigate the ratio of Thl7 cells and CD4+CD25+Foxp3+ regulatory T (Treg) cells in peripheral blood from patients with multiple myeloma (MM) and explore its pathological effects. Methods 70 MM patients were divided into three groups:newly diagnosed group (n=30), plateau stage group (n=23) and relapsed/refractory group (n=1 7). The controls consisted of 20 healthy donors. The frequencies of Thl7 and Treg cells were detected by flow cytometry. Results Compared with controls [ (0.72±0.33)% ] and plateau stage group [ (0.74±0.29)% ], frequencies of Thl 7 cells were higher in newly diagnosed group [ ( 1.62±0.65)% ] and relapsed/refractory group [ ( 1.45±0.51 )% ], respectively (P〈0.05). Compared with controls [ (2.33±0.90)%] and plateau stage group [ ( 1.69±0.70)%], frequencies of Treg cells were significantly lower in newly diagnosed group [ (0.55±0.23)% ] and relapsed/refractory group [ (0.82 ± 0.54) % ], respectively (P〈0.05). The ratios of Thl 7/Treg in newly diagnosed group and relapsed/refractory group were higher than those in controls (P〈0.05). There were no differences of the frequencies of CD3+CD4+T cells and Thl 7 cells between plateau stage group and controls. The frequencies of Treg cells were significantly lower in plateau stage group than that in controls (P〈0.05), and the ratio of ThlT/Treg was significantly higher in plateau stage group than that in controls (P〈0.05). Conclusion The remarkable abnormality of T cells subsets was reduction of CD4+ T cells in MM. Higher frequency of Thl7 and lower ratio of Treg could lead to imbalance of Thl7/Treg, which may play a critical role in the pathogenesis of MM.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2013年第11期936-940,共5页 Chinese Journal of Hematology
关键词 多发性骨髓瘤 TH17细胞 T淋巴细胞 调节性 Th17/Treg细胞比例 Multiple myeloma Thl7 cells T-lymphocytes, regulatory Thl7/Treg cells ratio
  • 相关文献

参考文献22

  • 1Mahindra A, Laubach J, Raje N, et al. Latest advances and cur- rent challenges in the treatment of multiple myeloma. Nat Rev Clin Oncol, 2012, 9:135-143. 被引量:1
  • 2Kuehl WM, Bergsagel PL. Molecular pathogenesis of multiple myeloma and its premalignant precursor. J Clin Invest, 2012, 122: 3456-3463. 被引量:1
  • 3Muller YD, Seebach JD, Bfihler LH, et al. Transplantation tolerance: Clinical potential of regulatory T cells. Self Nonself, 2011, 2: 26-34. 被引量:1
  • 4Zou W, Restifo NP. T(H)17 cells in tumour immunity and immu- notherapy. Nat Rev Immunol, 2010, 10: 248-256. 被引量:1
  • 5Chi LJ, Lu HT, Li GL, et al. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin Exp Immunol, 2010, 161: 480-489. 被引量:1
  • 6Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol, 2005, 116: 949-959. 被引量:1
  • 7Tesmer LA, Lundy SK, Sarkar S, et al. Thl7 cells in human disease. Immunol Rev, 2008, 223: 87-113. 被引量:1
  • 8张之南,沈悌主编..血液病诊断及疗效标准 第3版[M].北京:科学出版社,2007:271.
  • 9毛建华,陈志敏,汤永民,梁黎,杜立中,张扬.佛波酯对人外周血淋巴细胞CD3和CD4及CD8分子表达的作用[J].浙江大学学报(医学版),2004,33(2):155-159. 被引量:7
  • 10Goodyear OC, Pratt G, McLamon A, et al. Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma. Blood, 2008, 112: 3362-3372. 被引量:1

共引文献6

同被引文献111

  • 1许婷,唐亚男,何月茹,葛梦君,李护君,刘洋,李艳杰,姚瑶,李德鹏,程海,孙海英,徐开林,李振宇.NK细胞及调节性T细胞在多发性骨髓瘤中的表达水平及其意义[J].临床血液学杂志,2020,33(2):187-190. 被引量:8
  • 2刘会兰,孙自敏,杨会志,陈家萍,汪健,韩永胜,朱薇波,刘欣,耿良权,丁帮胜,翟志敏,王祖贻.自体外周血干细胞移植治疗急性髓细胞白血病[J].临床输血与检验,2007,9(4):313-315. 被引量:2
  • 3Beyer M,Kochanek M,Giese T,et al.In vivo peripheral expansion of naive CD4+ CD25high FoxP3+ regulatory T cells in patients with multiple myeloma[J].Blood,2006,107:3940-3949. 被引量:1
  • 4Feyler S,yon Lilienfeld-Toal M,Jarmin S,et al.CD4(+)CD25(+)FoxP3 (+) regulatory T cells are increased whilst CD3 (+)CD4(-)CD8 (-)alpha betaTCR (+) double negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden[J].Br J Haematol,2009,144:686-695. 被引量:1
  • 5Brimnes MK,Vangsted AJ,Knudsen LM,et al.Increased level of both CD4+ FOXP3+ regulatory T cells and CD14+ HLA-DR-low myeloidderived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma[J].Scand J Immunol,2010,72:540-547. 被引量:1
  • 6Muthu Raja KR,Rihova L,Zahradova L,et al.Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma[J].PloS One,2012,7:e47077. 被引量:1
  • 7Giannopoulos K,Kaminska W,Hus I,et al.The frequency of T regulatory cells modulates the survival of multiple myeloma patients:detailed characterisation of immune status in multiple myeloma[J].Br J Cancer,2012,106:546-552. 被引量:1
  • 8Prabhala RH,Neri P,Bae JE,et al.Dysfunctional T regulatory cells in multiple myeloma[J].Blood,2005,107:301-304. 被引量:1
  • 9Gupta R,Ganeshan P,Hakim M,et al.Significantly reduced regulatory T cell population in patients with untreated multiple myeloma[J].Leuk Res,2011,35:874-878. 被引量:1
  • 10Atanackovic D,Cao Y,Luetkens T,et al.CD4+ CD25+ FoxP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation[J].Haematologica,2008,93:423-430. 被引量:1

引证文献12

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部